drugset / Trial / NCT02543385

S Ketamine Use in Total Abdominal Hysterectomy

NCT02543385

RandomizedParallel-groupTriple-blindTreatment

Summary

This study investigates the effect of low dose S+ketamine compared to placebo on cumulative morphine consumption at 24 hours in women undergoing open abdominal hysterectomy with remifentanil-propofol target controlled infusion. It compares the adverse effect profile in patients receiving S+ketamine as compared to those who did not. Participants are randomly distributed in two groups of 45 patient's each.

Timeline

Start
2014-06
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esketamine Other / unclassified 0.25 mg/kg Intravenous

Indications

No indication recorded.